Literature DB >> 18758888

New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy: a prospective study of efficacy, safety and tolerability.

Elisabeth A Cats, W-Ludo van der Pol, Sanne Piepers, Nicoll C Notermans, R M van den Berg-Vos, L H van den Berg.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18758888     DOI： 10.1007/s00415-008-0979-3

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

Review 1.  Multifocal motor neuropathy.

Authors:  Jan-Thies H Van Asseldonk; Hessel Franssen; Renske M Van den Berg-Vos; John H J Wokke; Leonard H Van den Berg
Journal:  Lancet Neurol       Date:  2005-05       Impact factor: 44.182

2.  Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

Authors:  P Federico; D W Zochodne; A F Hahn; W F Brown; T E Feasby
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

3.  Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

4.  Multifocal motor neuropathy: response to human immune globulin.

Authors:  V Chaudhry; A M Corse; D R Cornblath; R W Kuncl; D B Drachman; M L Freimer; R G Miller; J W Griffin
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

5.  A 10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency.

Authors:  C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

6.  Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.

Authors:  L H Van den Berg; H Kerkhoff; P L Oey; H Franssen; I Mollee; M Vermeulen; F G Jennekens; J H Wokke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154
  6 in total
  3 in total

1.  Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registry.

Authors:  Martin Stangel; Ulrich Baumann; Michael Borte; Maria Fasshauer; Manfred Hensel; Dörte Huscher; Wilhelm Kirch; David Pittrow; Marcel Reiser; Ralf Gold
Journal:  J Clin Immunol       Date:  2012-09-14       Impact factor: 8.317

Review 2.  Immunoglobulin for multifocal motor neuropathy.

Authors:  Stephen Keddie; Filip Eftimov; Leonard H van den Berg; Ruth Brassington; Rob J de Haan; Ivo N van Schaik
Journal:  Cochrane Database Syst Rev       Date:  2022-01-11

3.  IqYmune® is an effective maintenance treatment for multifocal motor neuropathy: A randomised, double-blind, multi-center cross-over non-inferiority study vs Kiovig®-The LIME Study.

Authors:  Jean-Marc Léger; Ousmane Alfa Cissé; Dario Cocito; Jean-Marie Grouin; Haider Katifi; Eduardo Nobile-Orazio; Rabye Ouaja; Jean Pouget; Yusuf A Rajabally; Teresa Sevilla; Ingemar S J Merkies
Journal:  J Peripher Nerv Syst       Date:  2018-12-11       Impact factor: 3.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.